ResearcherUniversity of LeedsActive in the last 2 years
Samir Pathak
Matched on ORCID iD 0000-0002-0535-1470; OpenAlex author ID A5085372139. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 3, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 49
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 3 papers · 2025: 4 papers · 2026: 1 paper
Papers 12
- The impact of MRI on real-world staging pathways and management timelines in pancreatic cancer: A systematic review. Last author DOI 10.1016/j.ejso.2026.111779↗
- The impact of FDG-PET/CT on the diagnostic pathway of surgically treated pancreatic ductal adenocarcinoma: the Surg-Panc-UK study. Co-author DOI 10.1016/j.hpb.2025.05.003↗
- Impact of social deprivation upon the preoperative pathway and early surgical outcomes after pancreatoduodenectomy for PDAC and non-PDAC periampullary cancer i… Co-author DOI 10.1016/j.hpb.2025.07.007↗
- Quality assurance of surgical interventions for pancreatic cancer: systematic review of multicentre randomized clinical trials. Last author DOI 10.1093/bjsopen/zraf082↗
- Development and validation of a diagnostic prediction model for pancreatic ductal adenocarcinoma: VAPOR 1, protocol for a prospective multicentre case-control … Co-author DOI 10.1136/bmjopen-2024-094505↗
- Definition and management of intra-abdominal metachronous oligometastatic pancreatic cancer: a systematic review. Last author DOI 10.1093/bjs/znad338↗
- Editorial: Technological innovations and pancreatic cancer. Last author DOI 10.3389/fonc.2024.1497367↗
- Intra-Operative Tumour Detection and Staging in Pancreatic Cancer Surgery: An Integrative Review of Current Standards and Future Directions. Co-author DOI 10.3390/cancers16223803↗
- Evaluation of post-operative surveillance strategies and surgeon perceptions and beliefs of surveillance for pancreatic ductal adenocarcinoma in the UK. First author DOI 10.1016/j.hpb.2023.06.007↗
- Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. First author DOI 10.1016/j.hpb.2021.03.003↗
- Surgical Management of Non-Metastatic Pancreatic Cancer in the United Kingdom: Results of a Nationwide Survey on Current Practice. Co-author DOI 10.3389/fonc.2021.791946↗
- Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review. First author DOI 10.1111/hpb.12355↗
Closest collaborators
The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrew Malvern Smith · 5 shared papers, 2015–2026 · strength 1.16
- Paper The impact of MRI on real-world staging pathways and management timelines in pancreatic cancer: A systematic review. DOI 10.1016/j.ejso.2026.111779↗
- Paper Editorial: Technological innovations and pancreatic cancer. DOI 10.3389/fonc.2024.1497367↗
- Paper Quality assurance of surgical interventions for pancreatic cancer: systematic review of multicentre randomized clinical… DOI 10.1093/bjsopen/zraf082↗
- Keith John Roberts · 5 shared papers, 2021–2025 · strength 0.97
- Paper Evaluation of post-operative surveillance strategies and surgeon perceptions and beliefs of surveillance for pancreatic… DOI 10.1016/j.hpb.2023.06.007↗
- Paper The impact of FDG-PET/CT on the diagnostic pathway of surgically treated pancreatic ductal adenocarcinoma: the Surg-Pan… DOI 10.1016/j.hpb.2025.05.003↗
- Paper Development and validation of a diagnostic prediction model for pancreatic ductal adenocarcinoma: VAPOR 1, protocol for… DOI 10.1136/bmjopen-2024-094505↗
- Siobhan C. McKay · 4 shared papers, 2021–2025 · strength 0.80
- Paper Evaluation of post-operative surveillance strategies and surgeon perceptions and beliefs of surveillance for pancreatic… DOI 10.1016/j.hpb.2023.06.007↗
- Paper The impact of FDG-PET/CT on the diagnostic pathway of surgically treated pancreatic ductal adenocarcinoma: the Surg-Pan… DOI 10.1016/j.hpb.2025.05.003↗
- Paper Surgical Management of Non-Metastatic Pancreatic Cancer in the United Kingdom: Results of a Nationwide Survey on Curren… DOI 10.3389/fonc.2021.791946↗
- Mikolaj R. Kowal · 2 shared papers, 2024–2026 · strength 0.64
- Sanjay Pandanaboyana · 3 shared papers, 2015–2025 · strength 0.54
- Paper Editorial: Technological innovations and pancreatic cancer. DOI 10.3389/fonc.2024.1497367↗
- Paper Development and validation of a diagnostic prediction model for pancreatic ductal adenocarcinoma: VAPOR 1, protocol for… DOI 10.1136/bmjopen-2024-094505↗
- Paper Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreati… DOI 10.1111/hpb.12355↗
- John A. G. Moir · 2 shared papers, 2021–2025 · strength 0.41
- Paper The impact of FDG-PET/CT on the diagnostic pathway of surgically treated pancreatic ductal adenocarcinoma: the Surg-Pan… DOI 10.1016/j.hpb.2025.05.003↗
- Paper Surgical Management of Non-Metastatic Pancreatic Cancer in the United Kingdom: Results of a Nationwide Survey on Curren… DOI 10.3389/fonc.2021.791946↗
- Raneem Albazaz · 1 shared paper, 2026 · strength 0.33
- Mohammed Memon · 1 shared paper, 2026 · strength 0.33
- Jenifer Barrie · 1 shared paper, 2025 · strength 0.28
- Thomas Thorne · 1 shared paper, 2025 · strength 0.28
- Jack A. Helliwell · 1 shared paper, 2025 · strength 0.26
- Shailesh Vinayak Shrikhande · 1 shared paper, 2025 · strength 0.26
- Duncan R.C. Spalding · 2 shared papers, 2021–2025 · strength 0.25
- Paper Development and validation of a diagnostic prediction model for pancreatic ductal adenocarcinoma: VAPOR 1, protocol for… DOI 10.1136/bmjopen-2024-094505↗
- Paper Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. DOI 10.1016/j.hpb.2021.03.003↗
- Bilal A. Al-Sarireh · 2 shared papers, 2021–2025 · strength 0.25
- Paper Development and validation of a diagnostic prediction model for pancreatic ductal adenocarcinoma: VAPOR 1, protocol for… DOI 10.1136/bmjopen-2024-094505↗
- Paper Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. DOI 10.1016/j.hpb.2021.03.003↗
- Adam Enver Frampton · 2 shared papers, 2021–2025 · strength 0.25
- Paper Development and validation of a diagnostic prediction model for pancreatic ductal adenocarcinoma: VAPOR 1, protocol for… DOI 10.1136/bmjopen-2024-094505↗
- Paper Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. DOI 10.1016/j.hpb.2021.03.003↗
- Hemant Mahendrakumar Kocher · 2 shared papers, 2021–2025 · strength 0.25
- Paper Development and validation of a diagnostic prediction model for pancreatic ductal adenocarcinoma: VAPOR 1, protocol for… DOI 10.1136/bmjopen-2024-094505↗
- Paper Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. DOI 10.1016/j.hpb.2021.03.003↗
- Katie Boag · 1 shared paper, 2024 · strength 0.24
- Emily Britton · 1 shared paper, 2024 · strength 0.24
- Nigel Balfour Jamieson · 2 shared papers, 2021 · strength 0.21
- Paper Surgical Management of Non-Metastatic Pancreatic Cancer in the United Kingdom: Results of a Nationwide Survey on Curren… DOI 10.3389/fonc.2021.791946↗
- Paper Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. DOI 10.1016/j.hpb.2021.03.003↗
- Ahmed Kotb · 1 shared paper, 2024 · strength 0.20
- Yazan S. Khaled · 1 shared paper, 2024 · strength 0.20
- Nicole Lintern · 1 shared paper, 2024 · strength 0.20
- Ajith Kumar Siriwardena · 1 shared paper, 2025 · strength 0.17
- Caoimhe M. Walsh · 1 shared paper, 2025 · strength 0.17
- Zaed Z. R. Hamady · 1 shared paper, 2025 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.